mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |